Annual accounts receivable:
$6.97B-$560.59M(-7.45%)Summary
- As of today (August 20, 2025), GSK annual accounts receivable is $6.97 billion, with the most recent change of -$560.59 million (-7.45%) on December 31, 2024.
- During the last 3 years, GSK annual accounts receivable has fallen by -$1.49 billion (-17.65%).
- GSK annual accounts receivable is now -24.84% below its all-time high of $9.27 billion, reached on December 31, 2007.
Performance
GSK Accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly accounts receivable:
$10.03B+$920.93M(+10.11%)Summary
- As of today (August 20, 2025), GSK quarterly accounts receivable is $10.03 billion, with the most recent change of +$920.93 million (+10.11%) on June 30, 2025.
- Over the past year, GSK quarterly accounts receivable has increased by +$856.23 million (+9.33%).
- GSK quarterly accounts receivable is now -8.16% below its all-time high of $10.92 billion, reached on December 31, 2007.
Performance
GSK Quarterly accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
GSK Accounts receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -7.5% | +9.3% |
| 3 y3 years | -17.6% | +27.9% |
| 5 y5 years | -4.2% | +13.3% |
GSK Accounts receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -17.6% | +6.2% | -3.8% | +53.0% |
| 5 y | 5-year | -17.6% | +6.2% | -3.8% | +53.0% |
| alltime | all time | -24.8% | +1728.2% | -8.2% | +2532.5% |
GSK Accounts receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $10.03B(+10.1%) |
| Mar 2025 | - | $9.11B(+30.8%) |
| Dec 2024 | $6.97B(-7.4%) | $6.97B(-29.6%) |
| Sep 2024 | - | $9.90B(+7.9%) |
| Jun 2024 | - | $9.18B(+6.3%) |
| Mar 2024 | - | $8.63B(+14.6%) |
| Dec 2023 | $7.53B(+14.8%) | $7.53B(-27.8%) |
| Sep 2023 | - | $10.43B(+21.1%) |
| Jun 2023 | - | $8.61B(+2.0%) |
| Mar 2023 | - | $8.45B(+28.8%) |
| Dec 2022 | $6.56B(-22.5%) | $6.56B(-21.8%) |
| Sep 2022 | - | $8.38B(+6.9%) |
| Jun 2022 | - | $7.84B(-15.6%) |
| Mar 2022 | - | $9.29B(+9.8%) |
| Dec 2021 | $8.46B(+11.5%) | $8.46B(-18.5%) |
| Sep 2021 | - | $10.38B(+8.8%) |
| Jun 2021 | - | $9.53B(+6.5%) |
| Mar 2021 | - | $8.96B(+18.1%) |
| Dec 2020 | $7.59B(+4.4%) | $7.59B(-25.3%) |
| Sep 2020 | - | $10.15B(+14.6%) |
| Jun 2020 | - | $8.86B(-16.3%) |
| Mar 2020 | - | $10.58B(+45.5%) |
| Dec 2019 | $7.27B(+10.3%) | $7.27B(-27.8%) |
| Sep 2019 | - | $10.07B(+15.1%) |
| Jun 2019 | - | $8.75B(+2.5%) |
| Mar 2019 | - | $8.54B(+29.5%) |
| Dec 2018 | $6.59B(+4.3%) | $6.59B(-30.7%) |
| Sep 2018 | - | $9.51B(+9.8%) |
| Jun 2018 | - | $8.66B(+1.1%) |
| Mar 2018 | - | $8.57B(+35.5%) |
| Dec 2017 | $6.32B(+10.8%) | $6.32B(-27.4%) |
| Sep 2017 | - | $8.71B(+8.2%) |
| Jun 2017 | - | $8.05B(+3.4%) |
| Mar 2017 | - | $7.78B(+36.5%) |
| Dec 2016 | $5.70B(+1.2%) | $5.70B(-38.2%) |
| Sep 2016 | - | $9.22B(+18.1%) |
| Jun 2016 | - | $7.81B(-7.1%) |
| Mar 2016 | - | $8.41B(+49.2%) |
| Dec 2015 | $5.64B(+1.4%) | $5.64B(-37.0%) |
| Sep 2015 | - | $8.95B(+7.1%) |
| Jun 2015 | - | $8.36B(+2.4%) |
| Mar 2015 | - | $8.16B(+47.1%) |
| Dec 2014 | $5.56B(-15.4%) | $5.54B(-32.6%) |
| Sep 2014 | - | $8.22B(-3.8%) |
| Jun 2014 | - | $8.55B(-3.6%) |
| Mar 2014 | - | $8.87B(+35.0%) |
| Dec 2013 | $6.57B(-1.8%) | $6.57B(-22.1%) |
| Sep 2013 | - | $8.43B(-0.4%) |
| Jun 2013 | - | $8.47B(-1.7%) |
| Mar 2013 | - | $8.62B(+28.8%) |
| Dec 2012 | $6.69B | $6.69B(-26.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2012 | - | $9.06B(+4.7%) |
| Jun 2012 | - | $8.66B(-5.8%) |
| Mar 2012 | - | $9.19B(+33.2%) |
| Dec 2011 | $6.90B(-7.6%) | $6.90B(-24.8%) |
| Sep 2011 | - | $9.18B(-2.0%) |
| Jun 2011 | - | $9.36B(-1.8%) |
| Mar 2011 | - | $9.54B(+27.7%) |
| Dec 2010 | $7.47B(-16.2%) | $7.47B(-20.8%) |
| Sep 2010 | - | $9.43B(+4.8%) |
| Jun 2010 | - | $9.00B(-13.0%) |
| Mar 2010 | - | $10.34B(-1.5%) |
| Dec 2009 | $8.91B(+15.9%) | $10.50B(+8.5%) |
| Sep 2009 | - | $9.68B(+9.6%) |
| Jun 2009 | - | $8.83B(+4.0%) |
| Mar 2009 | - | $8.49B(-7.4%) |
| Dec 2008 | $7.69B(-17.1%) | $9.18B(-6.1%) |
| Sep 2008 | - | $9.77B(-9.1%) |
| Jun 2008 | - | $10.74B(+1.9%) |
| Mar 2008 | - | $10.55B(-3.5%) |
| Dec 2007 | $9.27B(+8.4%) | $10.92B(+6.2%) |
| Sep 2007 | - | $10.28B(+1.2%) |
| Jun 2007 | - | $10.16B(+0.8%) |
| Mar 2007 | - | $10.08B(+18.2%) |
| Dec 2006 | $8.55B(+12.9%) | $8.53B(+501.0%) |
| Sep 2006 | - | $1.42B(-84.6%) |
| Jun 2006 | - | $9.22B(+21.6%) |
| Dec 2005 | $7.58B(+4.4%) | $7.58B(+951.1%) |
| Sep 2005 | - | $721.56M(-1.0%) |
| Jun 2005 | - | $728.57M(-7.7%) |
| Mar 2005 | - | $789.60M(-90.8%) |
| Dec 2004 | $7.26B(+9.1%) | $8.54B(+7.3%) |
| Sep 2004 | - | $7.96B(+20.0%) |
| Dec 2003 | $6.65B(+17.5%) | $6.63B(-34.4%) |
| Mar 2003 | - | $10.12B(+78.5%) |
| Dec 2002 | $5.66B(+7.2%) | $5.67B(+7.6%) |
| Dec 2001 | $5.28B(+5.9%) | $5.27B(+5.9%) |
| Dec 2000 | $4.98B(+4.1%) | $4.97B(+83.0%) |
| Dec 1999 | $4.79B(+78.4%) | $2.72B(+1.9%) |
| Dec 1998 | $2.68B(+21.4%) | $2.67B(+19.9%) |
| Dec 1997 | $2.21B(-10.5%) | $2.22B(-9.2%) |
| Dec 1996 | $2.47B(+10.1%) | $2.45B(+75.2%) |
| Dec 1995 | $2.24B(+60.0%) | - |
| Jun 1994 | $1.40B(+2.3%) | $1.40B(+1.2%) |
| Jun 1993 | $1.37B(+0.2%) | $1.38B(+1.0%) |
| Jun 1992 | $1.37B(+28.8%) | $1.37B(+28.7%) |
| Jun 1991 | $1.06B(+15.6%) | $1.06B(+15.7%) |
| Jun 1990 | $918.56M(+42.1%) | $918.56M(+42.1%) |
| Jun 1989 | $646.27M(+10.3%) | $646.27M(+10.3%) |
| Jun 1988 | $586.14M(+22.6%) | $586.14M(+22.6%) |
| Jun 1987 | $478.15M(+25.5%) | $478.15M(+25.5%) |
| Jun 1986 | $381.10M | $381.10M |
FAQ
- What is GSK plc annual accounts receivable?
- What is the all time high annual accounts receivable for GSK plc?
- What is GSK plc annual accounts receivable year-on-year change?
- What is GSK plc quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for GSK plc?
- What is GSK plc quarterly accounts receivable year-on-year change?
What is GSK plc annual accounts receivable?
The current annual accounts receivable of GSK is $6.97B
What is the all time high annual accounts receivable for GSK plc?
GSK plc all-time high annual accounts receivable is $9.27B
What is GSK plc annual accounts receivable year-on-year change?
Over the past year, GSK annual accounts receivable has changed by -$560.59M (-7.45%)
What is GSK plc quarterly accounts receivable?
The current quarterly accounts receivable of GSK is $10.03B
What is the all time high quarterly accounts receivable for GSK plc?
GSK plc all-time high quarterly accounts receivable is $10.92B
What is GSK plc quarterly accounts receivable year-on-year change?
Over the past year, GSK quarterly accounts receivable has changed by +$856.23M (+9.33%)